[go: up one dir, main page]

AU2003246880A1 - Alkaloid-derived compounds and use thereof in cancer and malaria treatment - Google Patents

Alkaloid-derived compounds and use thereof in cancer and malaria treatment

Info

Publication number
AU2003246880A1
AU2003246880A1 AU2003246880A AU2003246880A AU2003246880A1 AU 2003246880 A1 AU2003246880 A1 AU 2003246880A1 AU 2003246880 A AU2003246880 A AU 2003246880A AU 2003246880 A AU2003246880 A AU 2003246880A AU 2003246880 A1 AU2003246880 A1 AU 2003246880A1
Authority
AU
Australia
Prior art keywords
alkaloid
cancer
derived compounds
malaria treatment
malaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246880A
Other versions
AU2003246880A8 (en
Inventor
Francois Frappier
Philippe Rasoanaivo
Suzanne Ratsimamanga
Alfred Francois Trigalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2003246880A8 publication Critical patent/AU2003246880A8/en
Publication of AU2003246880A1 publication Critical patent/AU2003246880A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2003246880A 2002-05-07 2003-04-30 Alkaloid-derived compounds and use thereof in cancer and malaria treatment Abandoned AU2003246880A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/05740 2002-05-07
FR0205740A FR2839513A1 (en) 2002-05-07 2002-05-07 NOVEL COMPOUNDS DERIVED FROM ALKALOIDS, THEIR PREPARATION PROCESS, AND THEIR USE FOR THE PREPARATION OF DRUGS
PCT/FR2003/001358 WO2003095459A2 (en) 2002-05-07 2003-04-30 Alkaloid-derived compounds and use thereof in cancer and malaria treatment

Publications (2)

Publication Number Publication Date
AU2003246880A8 AU2003246880A8 (en) 2003-11-11
AU2003246880A1 true AU2003246880A1 (en) 2003-11-11

Family

ID=29286369

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246880A Abandoned AU2003246880A1 (en) 2002-05-07 2003-04-30 Alkaloid-derived compounds and use thereof in cancer and malaria treatment

Country Status (3)

Country Link
AU (1) AU2003246880A1 (en)
FR (1) FR2839513A1 (en)
WO (1) WO2003095459A2 (en)

Also Published As

Publication number Publication date
AU2003246880A8 (en) 2003-11-11
WO2003095459A3 (en) 2004-04-08
WO2003095459A2 (en) 2003-11-20
FR2839513A1 (en) 2003-11-14

Similar Documents

Publication Publication Date Title
AU2003293376A1 (en) Anti-angiogenic compounds and their use in cancer treatment
AU2003209594A1 (en) Quinazoline compounds useful in therapy
AU2003213144A1 (en) Alkylating agent combinations in the treatment of cancer
AU2003272187A1 (en) Novel nanoparticles and use thereof
AU2003284242A1 (en) Methods and compositions for use in treating cancer
AU2003228445A1 (en) Tissue composites and uses thereof
AU2003214945A1 (en) Multi-function catheter and use thereof
AUPS054702A0 (en) Cancer therapy
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2002364051A1 (en) Anti-cancer combination and use thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003274963A1 (en) Mda-7 and free radicals in the treatment of cancer
AU2003255544A1 (en) Tumor specific oligosaccharide epitopes and use thereof
SG110107A1 (en) Compound and use in treatment
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003231803A1 (en) Treatment of cancer with mefloquire
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003220931A1 (en) 2-pyrone compounds and use thereof
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003219664A1 (en) Methods and therapeutic compositions in the treatment of advanced cancer
AU2004281077A1 (en) Methods and agents for the treatment of cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2003246880A1 (en) Alkaloid-derived compounds and use thereof in cancer and malaria treatment
AU2003240446A1 (en) Use of mob-5 in pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 493 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, APPLICATION NO. 2003246880, UNDER INID (43) CORRECT THE PUBLIC- ATION DATE TO READ 24.11.2003